2 Best Gene-Editing Stocks to Buy in July

Gene-editing stocks are favorites for biotech industry speculators thanks to their air of high-tech mystique and their potential to make blockbuster therapies. According to Market Research Future, the global genome editing market will expand at a compound annual growth rate of 18.3% over the next three years. Many investors may be willing to accept higher levels of risk to take advantage of that growth.

While there are a handful of promising gene-editing stocks, only a couple are worth buying today.

Image source: Getty Images.

Source Fool.com